Anadys hep C drug shows promise in mid-stage trial
by on Oct.13, 2011, under Health and Fitness
Anadys Pharmaceuticals Inc said a mid-stage trial showed that over three-fourths of untreated hepatitis C patients receiving a combination of its drug setrobuvir and the standard of care had undetectable virus levels at week 12.
View full post on Yahoo! Health News
